AbMax Biotechnology

AbMax has the world’s most advanced one-stop technology platform for antibodies and kits researching, which has the monoclonal antibody developed in an average of 46 days with a high success rate of 90%. Moreover, AbMax is also the fastest, best and most competitive service provider of antibody developing in China and one of the world’s best service providers of antibody developing. AbMax, as a member of biomedical field in the capital scientific and technological condition platform, is the training base of Beijing Normal University and also joins the Alliance of Bio-Box Outsourcing, China (ABO). AbMax has 300 square meters of office and 1200 square meters of experimental base, including the cell biology laboratory, the molecular biology laboratory, the biochemistry laboratory, the animal laboratory facilities in line with AAALAC and the GMP workshop of diagnostic reagents.